FR2589732B1 - Nouvelle formulation a liberation prolongee a base de pindolol - Google Patents

Nouvelle formulation a liberation prolongee a base de pindolol

Info

Publication number
FR2589732B1
FR2589732B1 FR868613668A FR8613668A FR2589732B1 FR 2589732 B1 FR2589732 B1 FR 2589732B1 FR 868613668 A FR868613668 A FR 868613668A FR 8613668 A FR8613668 A FR 8613668A FR 2589732 B1 FR2589732 B1 FR 2589732B1
Authority
FR
France
Prior art keywords
pindolol
release formulation
extended release
formulation based
new extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868613668A
Other languages
English (en)
French (fr)
Other versions
FR2589732A1 (fr
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2589732A1 publication Critical patent/FR2589732A1/fr
Application granted granted Critical
Publication of FR2589732B1 publication Critical patent/FR2589732B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR868613668A 1985-10-01 1986-10-01 Nouvelle formulation a liberation prolongee a base de pindolol Expired FR2589732B1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2589732A1 FR2589732A1 (fr) 1987-05-15
FR2589732B1 true FR2589732B1 (fr) 1989-07-13

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868613668A Expired FR2589732B1 (fr) 1985-10-01 1986-10-01 Nouvelle formulation a liberation prolongee a base de pindolol

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (de) * 2001-02-20 2008-10-15 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
KR870003777A (ko) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (ko) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (sv) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (nl) 2003-04-03
IE862565L (en) 1987-04-01
DK170016B1 (da) 1995-05-01
HK392A (en) 1992-01-10
ES2002508A6 (es) 1988-08-16
NZ217732A (en) 1990-07-26
DE3632201A1 (de) 1987-04-02
NL8602370A (nl) 1987-05-04
FR2589732A1 (fr) 1987-05-15
CA1298784C (en) 1992-04-14
SE8604112L (sv) 1987-04-02
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
DK464686D0 (da) 1986-09-29
ATA260486A (de) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (fr) 1987-04-02
AT402257B (de) 1997-03-25
CH669524A5 (de) 1989-03-31
PT83456B (pt) 1989-05-12
DE3632201C2 (de) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (nl) 2002-12-02
SE8604112D0 (sv) 1986-09-29
DK464686A (da) 1987-04-02
BE905516A (fr) 1987-03-30

Similar Documents

Publication Publication Date Title
IT8648450A0 (it) Composizione orale antitartaro
IT8648451A0 (it) Composizione orale antitartaro
BE865150A (fr) Base d'ancrage
BR8907584A (pt) Composicao de revestimento a base de fluorpolimero
IT8620877A0 (it) Composizione a base di benzina.
FR2634377B1 (fr) Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
IT8521654A0 (it) Formulazioni topiche a lento rilascio.
BR9002396A (pt) Composicao estabilizada a base de 3-isotiazolonas
ES2025120B3 (es) Dispositivo para decorar objetos
DK165034C (da) Markeringsindretning
ATA225988A (de) Selbstfaerbestempel
FR2589732B1 (fr) Nouvelle formulation a liberation prolongee a base de pindolol
PT91948A (pt) Processo para a preparacao de composicoes a base de poliamidas ignifugadas
FR2638755B1 (fr) Compositions durcissables a base de silicone
PT92682A (pt) Processo para a preparacao de uma composicao a base de trimebutina de libertacao prolongada
IT1213320B (it) Composizione farmaceutica orale a base di ubichinoni.
FR2521997B1 (fr) Nouvelle association medicamenteuse a base de morniflumate
KR890020863U (ko) 스탬프대
IT8647748A0 (it) Composizione orale antitartaro
FR2583042B1 (fr) Compositions analgesiques a base de (alkoxy-alkyl-hydroxy-phenyl) cyclohexanol
FR2586248B1 (fr) Insecticide a base de trihalogeno-imidazole
IT7805210A0 (it) Base di sostegno a piu' raggi per poltrone
KR880004605U (ko) 받침구가 부착된 비누
ES552148A0 (es) Procedimiento para preparar composiciones fungicidas a base de anilazinas
MX163870B (es) Composicion biocida a base de isotiazolona

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0174, 920507

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0167, 861001

CL Concession to grant licences
TP Transmission of property